title: Comparative doses and cost: esmolol versus labetalol during electroconvulsive therapy.
authors.forename: L
authors.initials: L
authors.lastname: Drop
authors.forename: I
authors.initials: I
authors.lastname: Castelli
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000191:economics; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000191:economics; D001794:Blood Pressure / Q000187:drug effects; D017046:Cost Savings; D016527:Drug Costs; D004565:Electroconvulsive Therapy / Q000009:adverse effects / Q000191:economics; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007741:Labetalol / Q000008:administration & dosage* / Q000191:economics; D011412:Propanolamines / Q000008:administration & dosage* / Q000191:economics; D013610:Tachycardia / Q000517:prevention & control; D013810:Therapeutic Equivalency
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D011412:Propanolamines; C036604:esmolol; D007741:Labetalol